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Abstract: Mercapto-substituted 1,2,4-triazoles are very interesting compounds as they play an
important role in chemopreventive and chemotherapeutic effects on cancer. In recent decades,
literature has been enriched with sulfur- and nitrogen-containing heterocycles which are used as a
basic nucleus of different heterocyclic compounds with various biological applications in medicine
and also occupy a huge part of natural products. Therefore, we shed, herein, more light on the
synthesis of this interesting class and its application as a biologically active moiety. They might also
be suitable as antiviral and anti-infective drugs.
Keywords: 1,2,4-triazole ring; synthesis; reactions; biological activity
1. Introduction
Taribavirin (I) (Figure 1) is a triazole based clinically used as antiviral drugs (Figure 1). It is an
active agent against a number of DNA and RNA viruses. It is indicated for severe respiratory syncytial
virus (RSV) infection, hepatitis C infection, and other viral infections like the West Nile virus and
dengue fever [1–3]. Taribavirin (also known as viramidine) is an antiviral drug in Phase III human
trials, but not yet approved for pharmaceutical use [4].
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Figure 1. Structure of anti-HIV active triazole drugs. 
AIDS is characterized by an abnormal host defense mechanism that predisposes to infections 
with opportunistic microorganisms [5]. It was reported [6] that compounds IIIa–d (Figure 1) have 
been proved as treatment for HIV-1. The viral enzymes, reverse transcriptase (RT), integrase (IN), 
i . tr t f ti- I ti t i l .
AIDS is characterized by an abnor al host defense echanis that predisposes to infections
with opportunistic icroorganis s [5]. It was reported [6] that co pounds IIIa–d (Figure 1) have
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been proved as treatment for HIV-1. The viral enzymes, reverse transcriptase (RT), integrase (IN),
and protease (PR) are all good drug targets. Two distinct types of RT inhibitors, both of which block
the polymerase activity of RT, have been approved to treat HIV-1 infections, nucleoside analogs
(NRTIs), and nonnucleosides (NNRTIs), and there are promising leads for compounds that either
block the RNase H activity or block the polymerase in other ways. A better understanding of the
structure and function(s) of RT and of the mechanism(s) of inhibition can be used to generate better
drugs; in particular, drugs that are effective against the current drug-resistant strains of HIV-1.NNRTIs
via high throughput screening (HTS) using a cell-based assay for inhibiting HIV-1 replication and
promising activities against selected NNRTI-resistant mutants such as Y181L, Y181C, K103N, and L100I
were observed.
Sulfanyltriazoles IIIa and IIIc (Figure 1) exhibited EC50 values of 182 and 24 nM, respectively,
suggesting the potential of these sulfanyltriazoles to overcome the K103-related NNRTI-resistant
mutants. These sulfanyltriazoles could serve as advanced lead structures promising great potential in
overcoming these and other NNRTI-resistant mutants [7].
1,2,4-triazoles are a very important class of compounds which attracted the attention of many
chemists and biologists in organic synthesis and medicinal and pharmaceutical fields due to their various
biological activities such as anticancer [8,9], antimicrobial, anticonvulsant [10], anti-inflammatory [11],
antitubercular [12], analgesic [13], antibacterial [14], and anti-HIV [15]. In addition, there
are chemotherapeutically known drugs containing 1,2,4-triazole moiety, e.g., fluconazole
(1) [16], (2-(2,4-difluorophenyl)-1,3-di(1H-1,2,4-triazol-1-yl)propan-2-ol) and itraconazole (2) [17],
(4-(4-(4-(4-(((2S,4R)-2-((1H-1,2,4-triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)
phenyl)piperazin-1-yl)-phenyl)-1-((S)-sec-butyl)-1H-1,2,4-triazol-5(4H)-one), which are used
as very effective antifungal drugs. In addition, prothioconazole (3) [18] is commercially
available for the treatment of plant-pathogenic fungal infections, alprazolam (4) [18],
(8-chloro-1-methyl-6-phenyl-4H-benzo[f ][1,2,4]triazolo[4,3-a][1,4]diazepine), is used for treating of
anxiety disorders, and anastrozole (5) [19] in addition to letrozole (6) is used for chemotherapeutic
anticancer drugs [20] (Figure 2).
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Figure 2. Some potent drugs contai i triazole and triazolethione moieties.
Incorporating of thione group either in 3- or 5-position (A and B, Figure 3) has been reported
in numerous reports, leading to enhancement of biological activities related to triazole moiety [21].
Besides, the triazolethione system is considered as a cyclic analog of very important components
like thiosemicarbazides and thiocarbohydrazides, which are widely spread as a reactive building
block in many organic reactions leading to different heterocyclic rings and having effective biological
applications. Many heterocyclic compounds are the main constituents of natural products; also,
mercapto-1,2,4-triazole nucleus is found in many natural products and pharmace ticals [22].
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Mercapto-1,2,4-triazole also may be derived from natural products by applying some reactions
to get the desired compounds [23].
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heterocyclic targets e sily obtained from different hydrazinecarbothioamides [38,39].
Schiff bases of triazol thiones [40] have played vital roles in organic synthesis and they are obtained
from triazolethiones using simple procedures; also, sometimes their structures poss ss biological and
pharmaceutical activiti s other than triazolethione itself such s anti-inflammatory and anti-oxidant [41],
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Various reactions of mercapto-triazolethiones [25] were discussed depending on S
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other heterocyclic compounds, e.g., triazolothiadiazines [51,52], imidazothiadiaz les [51,53],
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2. Synthesis of 1,2,4-Triazole-3-thiones
Hydrazinolysis of ethyl-substitut d benzoates 7a–c yielded the carbonylhydrazides 8a–c.
Nucleophilic addition of carbon disulfide (CS2) to 8a–c in basic media [22] gave the hydrazide
oxadiazole-2-thiones 9a–c. The reaction of oxadiazoles 9a–c with hydrazine hydrate in ethanol afforded
4-amino-5-aryl-1,2,4-triazole-3-thiones 10a–c (Scheme 1) [22].
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A series of 1,2,4-triazole-3-thiones 19a–d were successfully prepared through stepwise reaction
starting from esterification of N-(4-hydroxyphenyl)acetamide (14) with ethyl bromoacetate (15) to give
ethyl 2-(4-acetamido-phenoxy)acetate (16) [24]. The acetohydrazide 17 was then obtained through
hydrazinolysis of compound 16 with hydrazine hydrate. The corresponding thiosemicarbazides
18a–d were synthesized by the reaction of 17 with different isothiocyanates in dry ethanol. Finally,
thiosemicarbazide derivatives 18a–d were efficiently cyclized in basic media to give the desired
1,2,4-triazole-3-thiones 19a–d in 52–88% yields [24] (Scheme 3).
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The synthesis of 5-substituted phenyl-1,2,4-triazole-3-thiones 30a–c was done in high yields from
the refluxing of arylidene derivatives and trimethylsilyl isothiocyanate using sulfamic acid as a catalyst
via the intermediates 28a–c and 29a–c (Scheme 6) [52].
 synthesis of 5-subs ituted phenyl-1,2,4-triazole-3-thiones 30a–c was do e in h gh yields 
from the refluxing of arylidene derivatives and trimethylsilyl isothiocyanate using sulfamic acid as 
a catalyst via the intermediates 28a–c and 29a–c (Scheme 6) [52].  
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Sche e 7. Synthesis of triazolethiones 32a–c.
The reaction of diethyl 1-substituted-1H-1,2,3-triazole-4,5-dicarboxylates 33a–d with hydrazine
hydrate yielded diacid hydrazides 34a–d. Hydrazinecarbothioamides 35a–d were obtained via refluxing
of 34a–d with phenyl isothiocyanate. Dehydrative ring closure of compounds 35a–d under basic
condition furnished the formation of bis-1,2,4-triazole-3-thiones 36a–d in 80–85% yields. Besides, the
reaction of diacid hydrazides 34a–d with CS2 in basic solution followed by refluxing with hydrazine
hydrate gave bis-4-amino-1,2,4-triazole-3-thiones 37a–d in 80–85% yields (Scheme 8) [28]. The resulting
compounds were screened for their antimicrobial activities based on standard antimicrobial agents;
compound 37d exhibited comparable antibacterial and antifungal activities against all the tested
organisms [28].
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Screening of the synthesized compounds 42a–j against different microorganisms showed that they 
have good antifungal activity rather than antibacterial activity [56]. 
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Sche e 9. Synthesis of triazolethiones 40a–f. 
4- ethyl benzoylisothiocyanate as reacte  ith henylhy razine hy rate affor e  1- henyl-
5-(p-tolyl)-1 -1,2,4-triazole-3(2 )-thione (41). Schiff bases of triazolethione 42a–j ere obtaine  via 
reaction of triazolethione 41 ith for al ehy e an  vario s aro atic a ines (Sche e 10) [54]. 
Screening of the synthesize  co o n s 42a–j against ifferent icroorganis s sho e  that they 
have goo  antif ngal activity rather than antibacterial activity [56]. 
.
4- et l benzoylisothiocyanate was reacted with phenylhydrazine hydrate afforded
1-phen l-5-(p-tolyl)-1H-1,2,4-triazole-3(2H)-thione (41). Schiff bases of triazolethione 42a–j were
obtained via reaction of triazolethione 41 with formaldehyde and various aromatic amines
(Scheme 10) [54]. Screening of the sy thesized compounds 42a–j against different microorganisms
showed that they have good antifungal activity rather than antibacterial activity [56].
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were found active against the human breast cancer T47D cancer cell line with IC50 values of 43.4 and 
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c . t sis f tri l t i s f.
Pyridine-2,5-dicarbohydrazide (49) was synthesized from the reaction of
dimethylpyridine-2,5-dicarboxylic acid (48) with hydrazine hydrate, which reacted with
different alkyl/aryl isothiocyanates to afford 2,2′-(pyridine-2,5-dicarbonyl)bis-(N-substituted
hydrazinecarbothioamides) 50a–e. Ring closure of these hydrazine-carbothioamides 50a–e occurred in
basic media to give bis-1,2,4-triazole-3-thiones 51a–e in 85–95% yields (Scheme 12) [58]. Biological
activities of the synthesized compounds 51a–e were evaluated, and they showed high antioxidant
activity. Moreover, all of the synthesized compounds efficiently inhibited some metabolic enzymes
such as AChE (acetylcholinesterase I and II) and could be used as excellent candidate drugs in the
treatment of some diseases such as mountain sickness, glaucoma, gastric and duodenal ulcers, epilepsy,
osteoporosis, and neurological disorders [58].
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Ethyl (2-aroylaryloxy)acetates 53a–d were synthesized from hydroxyl-benzophenones 52a–d 
with ethyl chloroacetate. The reaction of 53a–d with hydrazine hydrate gave the corresponding 
acylhydrazides 54a–d. Intramolecular cyclization of 54a–d with CS2 in alkaline media resulted in 
oxadiazole-2-(3H)thiones 55a–d. 1,2,4-Triazolo-3-thiones 56a–d were synthesized from the reaction 
of compounds 55a–d with hydrazine hydrate. In addition, triazolothiadiazines 57a–d were 
synthesized from the reaction of 56a–d with phenacyl bromide [50]. The screening of compounds 
55a–d and 57a–d revealed that they possess a higher antibacterial activity than antifungal activity; 
also, the halo-substituted compounds showed an increased growth inhibition activity higher than 
that of the reference drugs such as fluconazole and chloramphenicol (Scheme 13) [50]. 
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Scheme 13. Synthesis of triazolethiones 57a–d.
Chlorosulfonati of ethyl 2-(3,4-dimethoxyphenyl)acetate (58) gave ethyl
2-(2-(chlorosulfonyl)-4,5-dimethoxyphenyl)acetate (59) (Scheme 14). Sulfonamides 60a–e were readily
obtained via reaction of 59 with secondary amines. The desired acid hydrazides 61a–e, which were
obtained by reaction of 60a–e with hydrazine hydrate, were condensed with various isothiocyanates to
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yield the corresponding hydrazinecarbothioamides 62a–e. Further, 1,2,4-Triazole-3-thiones 63a–e were
synthesized in 44–75% yields from the cyclization 62a–e in basic media (Scheme 14) [47]. Screening of
compounds 63a–e for in vitro antifungal and antibacterial activity revealed that they have the best
antifungal activity compared with the reference bifonazole in addition to the same bactericidal activity
as streptomycin, except for Enterobacter cloacae and Salmonella species [47].
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Various thiosemicarbazide derivatives 65a–c were then synthesized from the reaction of acid 
hydrazides 64a–c with 3-fluorophenyl isothiocyanates. Further, 1,2,4-triazole-3-thiones 66a–c were 
obtained from alkaline cyclization of compounds 65a–c with 8% NaOH solution (Scheme 16) [40]. 
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Various thiosemicarbazide derivatives 65a–c were then synthesized from the reaction of acid 
hydrazides 64a–c with 3-fluorophenyl isothiocyanates. Further, 1,2,4-triazole-3-thiones 66a–c were 
obtained from alkaline cyclization of compounds 65a–c with 8% NaOH solution (Scheme 16) [40]. 
. t i f - - i -t i l t i , .
Various thiosemicarbazide derivatives 65a–c were then synthesized from the reaction of acid
hydrazides 64a–c with 3-fluorophenyl isothiocyanates. Further, 1,2,4-triazole-3-thiones 66a–c were
obtained from alkaline cyclization of compounds 65a–c with 8% NaOH solution (Scheme 16) [40].
Molecules 2020, 25, 3036 11 of 54
 
Scheme 16. Synthesis of triazolethiones 66a–c. 
Treatment of oxadiazole thione 10a with hydrazine hydrate gave 4-amino-triazolethione (11a) 
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triazolethiones 67a–d with (2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate 
(68) in good yields (Scheme 17) [30]. The synthesized compounds were screened for their cytotoxic 
activity against human malignant cell lines (MCF-7 and Bel-7402). Interestingly, 69c showed more 
potent cytotoxic activity against MCF-7 cells compared with compound 67c. Compound 69b also 
was more active than compound 67b against MCF-7 and Bel-7402 cells [30]. 
 
Scheme 17. Synthesis of glycosides of triazolethiones 69a–d. 
A series of Pd complexes containing 1,2,4-triazole-3-thiones 71a–d [59] were synthesized from 
the reaction of different thiosemicarbazones 70a–d with diphenylphosphinopropane and K2[PdCl4] 
(Scheme 18). The reaction produced, as a minor product, compound 72 (Scheme 18) [59]. The in vitro 
cytotoxicity of 71a–d was evaluated against the MCF-7 cell line, with cisplatin as a reference. The 
complexes 71b and 71c showed significant cytotoxicity against the MCF-7 (human breast cancer) 
cell line compared with cisplatin [59]. 
Treat ent of oxadiazole thione 10a ith hydrazine hydrate gave 4-a ino-triazolethione (11a)
hich on reacting with various aldehydes gave the Schiff bases of triazolethiones 67a–d. The synthesis
of 1,3,4-trisubstituted triazolethiones 69a–d was carried out from the reaction of triazolethiones
67a–d with (2-(acetoxymethyl)-6-bromotetrahydro-2H-pyran-3,4,5-triyl triacetate (68) in good yields
(Scheme 17) [30]. The synthesized compounds were screened for their cytotoxic activity against
human malignant cell lines (MCF-7 and Bel-7402). Interestingly, 69c showed more potent cytotoxic
activity against MCF-7 cells compared with compound 67c. Compound 69b also was more active than
compound 67b against MCF-7 and Bel-7402 cells [30].
 .    . 
 .      . . t i f l i f t i l t i .
A series of Pd complexes containing 1,2,4-triazole-3-thiones 71a–d [59] were synthesized from
the reaction of different thiosemicarbazones 70a–d with diphenylphosphinopropane and K2[PdCl4]
(Scheme 18). The reaction produced, as a minor product, compound 72 (Scheme 18) [59]. The in vitro
cytotoxicity of 71a–d was evaluated against the MCF-7 cell line, with cisplatin as a reference.
The complexes 71b and 71c showed significant cytotoxicity against the MCF-7 (human breast cancer)
cell line compared with cisplatin [59].
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these compounds 74a–h occurred through refluxing with aqueous sodium hydroxide to give the 
target 1,2,4-triazole-3-thiones 75a–h in 78–88% yields. On the other side, when 2-
bromoacetophenone was reacted with 75a–h, the reaction gave the corresponding benzothioates 
76a–h in 74–86% yields (Scheme 19) [36]. Biological activity of compounds 74a–h and 76a–h showed 
that benzothioate 76a has a good antibacterial activity against all pathogenic bacteria compared 
with the standard chloramphenicol [36]. 
 
Scheme 19. Synthesis of S-alkylated triazolethiones 76a–h. 
It was reported that the Eschenmoser coupling reaction was used as an efficient method to get 
82–88% of diazenyl-1,2,4-triazole-5-thiones 79a–e via nucleophilic attack of disubstituted 
hydrazinecarbothioamides 77a–e on 2,3,5,6-tetrachloro-1,4-benzoquinone (78, p-CHL) which acted 
as a mediator [33] (Scheme 20). 
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aromatic isothiocyanates afforded the desired hydrazinecarbothioamides 74a–h. Ring closure of
these compounds 74a–h occurred through refluxing with aqueous sodium hydroxide to give the
target 1,2,4-triazole-3-thiones 75a–h in 78–88% yields. On the other side, when 2-bromoacetophenone
was reacted with 75a–h, the reaction gave the corresponding benzothioates 76a–h in 74–86% yields
(Scheme 19) [36]. Biological activity of compounds 74a–h and 76a–h showed that benzothioate
76a has a good antibacterial activity against all pathogenic bacteria compared with the standard
chloramphenicol [36].
 
c e e 18  S e    c exe   az e e  71a–  
fl i  f - f r - - l- - l- - r l - -c r r i es  it  iff r t 
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c e e 19. S t esis f -al late  triaz let i es 76a– . 
It s re rte  t t t e sc e ser c li  re cti  s se  s  efficie t et  t  et 
 f i e l- , , -tri le- -t i es  ia cle ilic tt c  f is stit te  
r i ec r t i i es   , , , -tetr c l r - , - e i e ( , - ) ic  cte  
s  e i t r [ ] ( c e e ). 
It was reported that the Eschenmoser coupling reaction was used as an efficient method
to get 82–88% of diazenyl-1,2,4-triazole-5-thiones 79a–e via nucleophilic attack of disubstituted
hydrazinecarbothioamides 77a–e on 2,3,5,6-tetrachloro-1,4-benzoquinone (78, p-CHL) which acted as a
mediator [33] (Scheme 20).
Molecules 2020, 25, 3036 13 of 54
 
Scheme 20. Synthesis of triazolethiones 79a–e. 
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Scheme 24. Synthesis f triazolethiones 97a–f.
The reaction of triazolethione 94 with different aldehydes in acidic media afforded (E)-4-(substituted
amino)-3-(1-(4-isobutylphenyl)ethyl)-4H-1,2,4-triazole-5-thiones 96a–f in 44–85% yields [61]. One-pot
multicomponent reaction of 96a–f, formaldehyde and secondary amines afforded 2,4,5-trisubstituted
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triazolethiones 97a–f. Screening of the anti-inflammatory activity of the synthesized compounds
revealed that Mannich bases (97b and 97e) exhibited the highest anti-inflammatory activity. Besides,
the most potent anti-inflammatory molecules 97b,d–f were further examined for their analgesic activity
in mice showing better analgesic activity compared to diclofenac [61].
Thiocarbohyrazide (38) was used efficiently as precursor of 4-amino-3-(1,2,3,4,5,6-
hexahydroxyhexyl)-1H-1,2,4-triazole-5(4H)-thione (99) through refluxing with D-glucoheptonic
acid-1,4-lactone (98) [62]. Besides, the triazole-thione 99 was reacted with different substituted
benzaldehydes to afford (E)-4-amino-3-(1,2,3,4,5,6-hexahydroxyhexyl)-1H-1,2,4-triazole-5(4H)- thiones
100a–f in good to moderate yields (50–70%). Introducing a glycosyl unit into triazolethiones Schiff
bases 100a–f led to good water-solubility of these compounds and also improved their biological
activities (Scheme 25) [62].
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The reaction of different carboxylic acids with thiocarbohydrazide 38 gave aminotriazolethiones
11d,f–j in 51–57% yields. In a different manner, the reaction of 38 with ethyl esters of
γ-keto acids did not give the expected triazolethiones 104a,b but it gave 6-substituted
phenyl-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazine-3(2H)-thiones 105a,b in 35% and 39% yields.
The reaction occurred via ring closure of triazole and intramolecular imine condensation of 104a,b
(Scheme 27) [64]. The prepared compounds were tested for their inhibitory activities against
Mycobacterium bovis BCG; compound 11d proved to be the most potent one against it, with MIC
value of 31.25 µg/mL [64].
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Reaction of 2-(coumarin-4-yl)acetic acid with thiocarbohydrazide (38) in refluxing phosphoryl
chloride yielded the target 4-((4-amino-5-thioxo-4,5-dihydro-1H-1,2,4-triazole-3-yl)methyl)-2H-
chromen-2-one (111) in 80% yield. Condensation of 111 with various aromatic aldehydes yielded
(E)-4-((4-(benzylideneamino)-5-thioxo-4,5-dihydro-1H-1,2,4-triazole-3-yl)methyl)-2H-chromen-2-ones
112a–c (Scheme 29) [37]. The synthesized compounds were evaluated in vitro as anticancer agents
in the human colon cancer (HCT 116) cell line. Compound 112c showed high anticancer activity
(relative potency >50%) with IC50 value of 4.363 µM compared to the potent anticancer drug
doxorubicin, whereas compound 112a displayed moderate anticancer activity with IC50 values
18.76 µM. The molecular docking studies of the active compounds revealed that these compounds
might act via inhibition of tyrosine kinases (CDK2) [37].
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120 gave 2-((4-allyl-5-((diphenylphosphoryl)methyl)-4H-1,2,4-triazole-3-yl)thio)acetohydrazide (121)
in 43% yield (Scheme 31) [42].
 
Scheme 30. Synthesis of triazolethiones 116a–e. 
Phosphorylated triazolethione 119 was formed in 90% yield from the cyclization process of N-
allyl-2-(2-(diphenylphosphoryl)acetyl)hydrazinecarbothioamide 118 (obtained from 2-
(diphenylphosphoryl)acetohydrazide (117) with allyl isothiocyanate) in basic media (5%) NaOH 
[42]. Moreover, ethyl 2-((4-allyl-5-((diphenylphosphoryl)-methyl)-4H-1,2,4-triazole-3-yl)thio)acetate 
(120) was synthesized in 68% yield by reacting 119 with ethyl bromoacetate. Hydrazinolysis of 
compound 120 gave 2-((4-allyl-5-((diphenylphosphoryl)methyl)-4H-1,2,4-triazole-3-
yl)thio)acetohydrazide (121) in 43% yield (Scheme 31) [42]. 
 
Scheme 31. Synthesis of triazolethione 121. 
Incorporating of triazolethiones into thiazole ring was the optimum pharmacophore model for 
anticonvulsant activities, thus condensation of ethyl thiazol-2-ylcarbamates 122a–d with 4-
substituted thiosemicarbazides 23c–f afforded the corresponding hydrazinecarbothioamides 123a–
d. Cyclization of the latter with aqueous sodium hydroxide gave 4-substituted phenyl-3-((4-aryl-
4,5-dihydrothiazol-2-yl)amino)-1H-1,2,4-triazole-5(4H)-thiones 124a–d in 62–84% yields [66] 
(Scheme 32). The obtained compounds were screened for their anticonvulsant activity and showed 
that compounds 124d and 124e had a significant anticonvulsant activity compared with the 
standard drugs [66]. 
.
I c r r ti f triazolethiones into thiazole ring was the optimum pharmacophore model
for anticonvulsant activities, thus co densati n of ethyl thiazol-2-ylcarbamates 122a–d with
4-substituted thiosemicarbazides 23c–f afforded the corresponding hydrazinecarbothioamides
123a–d. Cyclization of th latter with aque us sodium hy roxide gave 4-substituted phenyl-3-((4-
aryl-4,5- ihydrothiazol-2-yl)amino)-1H-1,2,4-triazole-5(4H)-thiones 124a–d in 62–84% yields [ ]
( ). t i s r s r f r t ir ti ls t ti it s
t t compounds 124d and 124e had a significa t anticonvulsa t activity ompared with the standard
drugs [66].
 
Scheme 32. Synthesis of 2,4-triazole-5(4H)-thiones 124a–d. 
The condensation of (E)-1-(phenoxathiin-2-yl)-3-phenylprop-2-en-1-one (125) with 
malononitrile afforded 2-amino-6-(phenoxathiin-2-yl)-4-phenylnicotinonitrile (126). In addition, 
compound 126 reacted with triethyl orthoformate in acetic anhydride to give formimide 127, which 
upon hydrazinolysis with phenyl hydrazine yielded 4-imino-7-(phenoxathiin-2-yl)-5-
phenylpyrido[2–d]pyrimidin-3(4H)-amine (128). The reaction of the latter with CS2 gave 16-phenyl-
[1,2,4]triazolo-pyrimido[4–b]benzo[5,6][1,4]oxathiino[3,2-g]quinoline-2(3H)-thiones 129 (Scheme 33) 
[50]. 
 
Scheme 33. Synthesis of [1,2,4]triazolo-pyrimido[4–b]benzo[5,6][1,4]oxathiino[3,2-g]quinoline-2(3H)-
thiones 129. 
2-(Adamantanyl-1-carbonyl)-N-phenylhydrazinecarbothioamide (130) was synthesized from 
the reaction of adamantane-1-carbohydrazide (9d) with phenyl isothiocyanate. Thereafter, 3-
(adamantan-1-yl)-4-phenyl-1H-1,2,4-triazole-5(4H)-thione 131a was synthesized via basic hydrolysis 
of 130a with NaOH. Then, 3-(adamantan-1-yl)-1-((piperidin-4-yl)methyl)-4-phenyl-1H-1,2,4-
triazole-5(4H)-thiones 132a–f were obtained from the reaction of compound 131a with 1-substituted 
piperazine and formaldehyde solution [34] (Scheme 34). The synthesized N-Mannich bases of 
triazolethiones 132b–f screened against Gram-positive and -negative bacteria in addition to some 
pathogenic fungus (Candida albicans) revealed that they had potent antibacterial activity [34]. 
The condensation of (E)-1-(phenoxathiin-2-yl)-3-phenylprop-2-en-1-one (125) with malononitrile
afforded 2-amino-6-(phenoxathiin-2-yl)-4-phenylnicotinonitrile (126). In addition, compound 126
reacted with triethyl orthoformate in acetic anhydride to give formimide 127, which upon
hydrazinolysis with phenyl hydrazine yielded 4-imino-7-(phenoxathiin-2-yl)-5-phenylpyrido[2-
Molecules 2020, 25, 3036 19 of 54
d]pyrimidin-3(4H)-amine (128). The reaction of the latter with CS2 gave 16-phenyl-[1,2,4]triazolo-
pyrimido[4-b]benzo[5,6][1,4]oxathiino[3,2-g]quinoline-2(3H)-thiones 129 (Scheme 33) [50].
 
Scheme 32. Synthesis of 2,4-triazole-5(4H)-thiones 124a–d. 
The condensation of (E)-1-(phenoxathiin-2-yl)-3-phenylprop-2-en-1-one (125) with 
malononitrile afforded 2-amino-6-(phenoxathiin-2-yl)-4-phenylnicotinonitrile (126). In addition, 
compound 126 reacted with triethyl orthoformate in acetic anhydride to give formimide 127, which 
upon hydrazinolysis with phenyl hydrazine yielded 4-imino-7-(phenoxathiin-2-yl)-5-
phenylpyrido[2–d]pyrimidin-3(4H)-amine (128). The reaction of the latter with CS2 gave 16-phenyl-
[1,2,4]triazolo-pyrimido[4–b]benzo[5,6][1,4] xathiino[3,2-g]quinoline-2(3H)-thiones 129 (Scheme 33) 
[50]. 
 
Scheme 33. Synthesis of [1,2,4]triazolo-pyrimido[4–b]benzo[5,6][1,4]oxathiino[3,2-g]quinoline-2(3H)-
thiones 129. 
2-(Adamantanyl-1-carbonyl)-N-phenylhydrazinecarbothioamide (130) was synthesized from 
the reaction of adamantane-1-carbohydrazide (9d) with phenyl isothiocyanate. Thereafter, 3-
(adamantan-1-yl)-4-phenyl-1H-1,2,4-triazole-5(4H)-thione 131a was synthesized via basic hydrolysis 
of 130a with NaOH. Then, 3-(adamantan-1-yl)-1-((piperidin-4-yl)methyl)-4-phenyl-1H-1,2,4-
triazole-5(4H)-thiones 132a–f were obtained from the reaction of compound 131a with 1-substituted 
piperazine and formaldehyde solution [34] (Scheme 34). The synthesized N-Mannich bases of 
triazolethiones 132b–f screened against Gram-positive and -negative bacteria in addition to some 
pathogenic fungus (Candida albicans) revealed that they had potent antibacterial activity [34]. 
. -
i .
2-(Ada antanyl-1-carbonyl)-N-phenylhydrazinecarbothioamide (130) was synthesized from the
reaction of adamantane-1-carbohydrazide (9d) with phenyl isothiocyanate. Thereafter, 3-(adamantan-
1-yl)-4-phenyl-1H-1,2,4-triazole-5(4H)-thione 131a was synthesized via basic hydrolysis of 130a with
NaOH. Then, 3-(adamantan-1-yl)-1-((piperidin-4-yl)methyl)-4-phenyl-1H-1,2,4-triazole-5(4H)-thiones
132a–f were obtained from the reaction of compound 131a with 1-substituted piperazine and
formaldehyde solution [34] (Scheme 34). The synthesized N-Mannich bases of triazolethiones 132b–f
screened against Gram-positive and -negative bacteria in addition to some pathogenic fungus (Candida
albicans) revealed that they had potent antibacterial activity [34].
 
Scheme 34. Synthesis of 1,2,4-triazole-5(4H)-thiones 132a–f. 
Hydrolysis of disubstituted hydrazinecarbothioamides 130b–d with aqueous sodium 
hydroxide gave 1,2,4-triazole-5-thiones 92b–d. Mannich reaction of 1,2,4-triazole-5-thiones 92b–d, 1-
[(1R,2S)-2-fluorocyclopropyl]CPFX (133) and formaldehyde afforded 1-[(1R,2S)-2-
fluorocyclopropyl]CPFX-1,2,4-triazole-5-thiones 134a–c in 52–57% yields (Scheme 35) [67]. 
 
Scheme 35. Synthesis of 1,2,4-triazole-thiones of 1-[(1R,2S)-2-fluorocyclopropyl]-CPFX 134a–c. 
Antibacterial activity against different pathogens showed that all of the CPFX-1,2,4-triazole-5-
thiones 134a–c were more potent than the parent 1-[(1R,2S)-2-fluorocyclopropyl]-CPFX 133 and 
comparable to ciprofloxacin and levofloxacin against the majority of the tested pathogens. 
Moreover, the anti-Gram negative bacterial activity of 134a–c was far more potent than the 
reference named Vancomycin (VAN) [53]. 
The reaction of acid hydrazide 9e–g and 2-(4-isothiocyanatophenyl)-1H-benzo[d]imidazole 
gave N-(4-(1H-benzimidazol-2-yl)phenyl)-2-benzoylhydrazine-carbothioamides 135. Ring closure of 
compound 135 in acidic media afforded 1,2,4-triazole-5-thiones 136 [28] in 55–64% yields (Scheme 
36). Screening of the obtained compounds for antibacterial and antifungal activities showed that 
some of these compounds exhibited good antibacterial and antifungal activities [28].  
Scheme 34. Synthesis of 1,2,4-triazole-5(4H)-thiones 132a–f.
Hydrolysis of disubstituted hydrazinecarbothioamides 130b–d ith aqueous sodiu
hydroxide gave 1,2,4-triazole-5-thiones 92b–d. Mannich reaction of 1,2,4-triazole-5-thiones 92b–d,
Molecules 2020, 25, 3036 20 of 54
1-[(1R,2S)-2-fluorocyclopropyl]CPFX (133) and formaldehyde afforded 1-[(1R,2S)-2-fluorocyclopropyl]
CPFX-1,2,4-triazole-5-thiones 134a–c in 52–57% yields (Scheme 35) [67].
 
Scheme 34. Synthesis of 1,2,4-triazole-5(4H)-thiones 132a–f. 
Hydrolysis of disubstituted hydrazinecarbothioamides 130b–d with aqueous sodium 
hydroxide gave 1,2,4-triazole-5-thiones 92b–d. Mannich reaction of 1,2,4-triazole-5-thiones 92b–d, 1-
[(1R,2S)-2-fluorocyclopropyl]CPFX (133) and formaldehyde afforded 1-[(1R,2S)-2-
fluorocyclop opy ]CPFX-1,2,4-tri zole-5-thiones 134a–c in 52–57% yields (Scheme 35) [67]. 
 
Scheme 35. Synthesis of 1,2,4-triazole-thiones of 1-[(1R,2S)-2-fluorocyclopropyl]-CPFX 134a–c. 
Antibacterial activity against different pathogens showed that all of the CPFX-1,2,4-triazole-5-
thiones 134a–c were more potent than the parent 1-[(1R,2S)-2-fluorocyclopropyl]-CPFX 133 and 
comparable to ciprofloxacin and levofloxacin against the majority of the tested pathogens. 
Moreover, the anti-Gram negative bacterial activity of 134a–c was far more potent than the 
reference named Vancomycin (VAN) [53]. 
The reaction of acid hydrazide 9e–g and 2-(4-isothiocyanatophenyl)-1H-benzo[d]imidazole 
gave N-(4-(1H-benzimidazol-2-yl)phenyl)-2-benzoylhydrazine-carbothioamides 135. Ring closure of 
compound 135 in acidic media afforded 1,2,4-triazole-5-thiones 136 [28] in 55–64% yields (Scheme 
36). Screening of the obtained compounds for antibacterial and antifungal activities showed that 
some of these compounds exhibited good antibacterial and antifungal activities [28].  
fl
Antibacterial activity against different pathogens showed that all of the
CPFX-1,2,4-triazole-5-thiones 134a–c were more potent than the parent 1-[(1R,2S)-2-fluorocyclopropyl]-
CPFX 133 and comparable to ciprofloxacin and levofloxacin against the majority of the tested
pathogens. Moreover, the anti-Gram negative bacterial activity of 134a–c was far more potent than the
reference na ed Vanco ycin (VAN) [67].
The reaction of acid hydrazide 9e–g and 2-(4-isothiocyanatophenyl)-1 -benzo[d]i idazole
gave -(4-(1 -benzi idazol-2-yl)phenyl)-2-benzoylhydrazine-carbothioa ides 135. Ring closure of
co pound 135 in acidic media afforded 1,2,4-triazole-5-thiones 136 [28] in 55–64% yields (Scheme 36).
Screening of the obtained compounds for antibacterial and antifungal activities showed that some of
these compounds exhibited good antibacterial and antifungal activities [28].
 
Scheme 36. Synthesis of 1,2,4-triazole-thiones 136. 
Condensation of 4-amino-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbonitrile (137) with 
triethyl orthoformate in the presence of acetic anhydride as catalyst gave (Z)-ethyl N-(5-cyano-3-
methyl-1-phenyl-1H-thieno[2,3-c]pyrazol-4-yl)formimidate (138). Hydrazinolysis of 138 with 
hydrazine hydrate yielded 7-imino-3-methyl-1-phenyl-1H-pyrazolothieno[3,2-d]pyrimidin-6(7H)-
amine (139), whereas cyclization of pyrazolothienopyrimidines 139 with CS2 afforded 7-methyl-9-
phenyl-3,9-dihydro-2H-pyrazolothieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine-2-thione (140) in 35% 
yield (Scheme 37) [54].  
 
Scheme 37. Synthesis of 1,2,4- pyrazolothieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine-2-thione 140. 
The cyclization reaction of longer alkenyl/hydroxyl alkenyl acid hydrazides 9h–k CS2/KOH 
followed by treatment with hydrazine hydrate yielded the corresponding 4-amino-3-substituted-
1H-1,2,4-triazole-5(4H)-thiones 11k–n. 1,2,4-Triazolothiadiazines 141a–d were directly obtained 
from the reaction of amino triazolethiones 11k–n with phenacyl bromide in 62–90% yields (Scheme 
38). In vitro screening of anticancer activity against three different cell lines, i.e., human 
hepatocellular carcinoma (Hep3B), human breast adenocarcinoma (MCF7), and human cervical 
carcinoma (HeLa), towards triazolethione and triazolothiadiazines showed that the nature of the 
long-chain on third position affected the potency of these drugs. Besides, fused triazolothiadiazines 
141a–d were found to be potential anticancer agents [68]. 
 
s ti f - i - - t l- - l- -t i [ , -c] r l - -c r itril ( ) it
triet l rt f r te i t e rese ce f cetic ri e s c t l st e ( )-et l -( -c - -
t l- - l- -t ie o[2,3-c]pyrazol-4-yl)formimidate ( ). Hydrazinolysis of 138 it
r i e r te yielde 7-imino-3-methyl-1-phenyl-1 - r l t ie [ , - ] ri i i - ( )-
i ( ), r s c cli ti f r l t i ri i i s it ff r - t l- -
l- , - i r - - r z lothieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine-2-thione (140) in
iel ( c e e ) [ ].
Molecules 2020, 25, 3036 21 of 54
 
Scheme 36. Synthesis of 1,2,4-triazole-thiones 136. 
Condensation of 4-amino-3-methyl-1-phenyl-1H-thieno[2,3-c]pyrazole-5-carbonitrile (137) with 
triethyl orthoformate in the presence of acetic anhydride as catalyst gave (Z)-ethyl N-(5-cyano-3-
methyl-1-phenyl-1H-thieno[2,3-c]pyrazol-4-yl)formimidate (138). Hydrazinolysis of 138 with 
hydrazine hydrate yielded 7-imino-3-methyl-1-phenyl-1H-pyrazolothieno[3,2-d]pyrimidin-6(7H)-
amine (139), whereas cyclization of pyrazolothienopyrimidines 139 with CS2 afforded 7-methyl-9-
phenyl-3,9-dihydro-2H-pyrazolothieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine-2-thione (140) in 35% 
yield (Scheme 37) [54].  
 
Scheme 37. Synthesis of 1,2,4- pyrazolothieno[2,3-e][1,2,4]triazolo[1,5-c]pyrimidine-2-thione 140. 
The cyclization reaction of longer alkenyl/hydroxyl alkenyl acid hydrazides 9h–k CS2/KOH 
followed by treatment with hydrazine hydrate yielded the corresponding 4-amino-3-substituted-
1H-1,2,4-triazole-5(4H)-thiones 11k–n. 1,2,4-Triazolothiadiazines 141a–d were directly obtained 
from the reaction of amino triazolethiones 11k–n with phenacyl bromide in 62–90% yields (Scheme 
38). In vitro screening of anticancer activity against three different cell lines, i.e., human 
hepatocellular carcinoma (Hep3B), human breast adenocarcinoma (MCF7), and human cervical 
carcinoma (HeLa), towards triazolethione and triazolothiadiazines showed that the nature of the 
long-chain on third position affected the potency of these drugs. Besides, fused triazolothiadiazines 
141a–d were found to be potential anticancer agents [68]. 
 
c e e 37. Synthesis of 1,2,4- razolot ie o[2,3-e][1,2,4]triazolo[1,5-c] ri i i e-2-t io e 140.
The cyclization reaction of longer alkenyl/hydroxyl alkenyl acid hydrazides 9h–k
CS2/KOH followed by treatment with hydrazine hydrate yielded the corresponding
4-amino-3-substituted-1H-1,2,4-triazole-5(4H)-thiones 11k–n. 1,2,4-Triazolothiadiazines 141a–d were
directly obtained from the reaction of amino triazolethiones 11k–n with phenacyl bromide in 62–90%
yields (Scheme 38). In vitro screening of anticancer activity against three different cell lines, i.e.,
human hepatocellular carcinoma (Hep3B), human breast adenocarcinoma (MCF7), and human cervical
carcinoma (HeLa), towards triazolethione and triazolothiadiazines showed that the nature of the
long-chain on third position affected the potency of these drugs. Besides, fused triazolothiadiazines
141a–d were found to be potential anticancer agents [68].
 
Scheme 38. Synthesis of fused triazolothiadiazines 141a–d. 
Similarly, the reaction of acid hydrazides 142a–i with isothiocyanates afforded the 
acylhydrazides 143a–i (Scheme 39). The triazolethiones 144a–i were then obtained in 62–90% yields 
from the reaction of thiosemicarbazides 143a–i in NaHCO3 in ethanol (Scheme 39) [69]. The 1,2,4-
triazolethione 144g was found to be the best anti-inflammatory nucleus via inhibiting both COX-2 
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Similarly, the reaction of acid hydrazides 142a–i with isothiocyanates afforded the acylhydrazides
143a–i (Scheme 39). The triazolethiones 144a–i were then obtained in 62–90% yields from the reaction
of thiosemicarbazides 143a–i in NaHCO3 in ethanol (Scheme 39) [69]. The 1,2,4-triazolethione 144g was
found to be the best anti-inflammatory nucleus via inhibiting both COX-2 (IC50 = 2.1 µM) and 5-LOX
(IC50 = 2.6 µM) enzymes, and this was supported via enzyme-ligand molecular modeling (docking
studies), which gave favorable binding interactions in both COX-2 and 5-LOX active sites. It also has a
superior gastrointestinal safety profile (ulcer index = 0.25) compared to the reference drug [69].
Molecules 2020, 25, 3036 22 of 54
 
Scheme 38. Synthesis of fused triazolothiadiazines 141a–d. 
Similarly, the reaction of acid hydrazides 142a–i with isothiocyanates afforded the 
acylhydrazides 143a–i (Scheme 39). The triazolethiones 144a–i were then obtained in 62–90% yields 
from the reaction of thiosemicarbazides 143a–i in NaHCO3 in ethanol (Scheme 39) [69]. The 1,2,4-
triazolethione 144g was found to be the best anti-inflammatory nucleus via inhibiting both COX-2 
(IC50 = 2.1 μM) and 5-LOX (IC50 = 2.6 μM) enzymes, and this was supported via enzyme-ligand 
molecular modeling (docking studies), which gave favorable binding interactions in both COX-2 
and 5-LOX active sites. It also has a superior gastrointestinal safety profile (ulcer index = 0.25) 
compared to the reference drug [69]. 
 
Scheme 39. Synthesis of triazolethiones 144a–i. 
Interestingly, esterification of 1H-benzimidazoles 145a–e with ethyl chloroacetate gave ethyl 2-
(2-phenyl-1H-benzo[d]imidazol-1-yl)acetates 146a–e, which upon reacting with hydrazine hydrate 
gave the acid hydrazide 147a–e. Also, N-methyl-2-(2-(2-phenyl-1H-benzo[d]imidazol-1-
yl)acetyl)hydrazinecarbothioamides 148a–e were formed by the reaction 147a–e with methyl 
isothiocyanate. Ring closure of hydrazine-carbothioamides 148a–e with aqueous NaOH afforded 
the biologically active triazolethiones 149a–e in 51–64% yields, with significant antioxidant 
properties (Scheme 40) [70]. 
I teresti l , esterification of 1H-benzimidazoles 145a–e with ethyl chloroacetate gave
ethyl 2-(2-phenyl-1H-benzo[d]imidazol-1-yl)acet t s 146a–e, which upon reacting with hydrazin
hydrate gave the acid hydrazide 147a–e. Also, N-methyl-2-(2-(2-phenyl-1H-benzo[d]imidazol-1-yl)
acetyl)hydrazinecarbothioamides 148a–e wer formed by the reaction 147a–e it t l
is t i c t . i closure of hydrazine-carbothioamides 148a–e with aqueous NaOH afforded the
biologically ctive triazolethi nes 149a–e in 51–64% yields, with significant antioxidant properties
(Scheme 40) [70].
 
Scheme 40. Synthesis of triazolethiones 149a–e. 
Reaction of 2-((3,5,6-trichloropyridin-2-yl)oxy)acetic acid (150) with thionyl chloride gave 
compound 151. Additionally, the treatment of compound 151 with hydrazine hydrate gave (3,5,6-
trichloropyridin-2-yl)hydrazine-carboxylate (152). When the acid hydrazide 152 was then subjected 
to aqueous potassium thiocyanate, 2-(2-((3,5,6-trichloropyridin-2-yl)oxy)acetyl)hydrazine-
carbothioamide (153) was obtained. Cyclization of 153 in basic media afforded 1H-1,2,4-triazole-
5(4H)-thione 154) [71]. On the other side, various S-alkylated products 155a–e were obtained via 
reacting substituted benzyl chlorides with triazolethiones 154. However, the reaction of 
morpholine, formaldehyde, and compound 155a–e gave the N-alkylated morpholino-
triazolethiones 156a–e, which on oxidation with H2O2 in acidic media gave 3,4,5-trisubstituted-1,2,4-
triazoles 157a–e in 54–69% yields [71]. The synthesized compounds 157a–e screened for their 
antimicrobial activity revealed that 157c exhibited better antibacterial and antifungal activities than 
the other compounds (Scheme 41) [71]. 
 
c e e 40. S t esis f triaz let i es 149a–e.
Reaction of 2-((3,5,6-trichloropyridin-2-yl)oxy)acetic acid (150) with thionyl chloride gave
compound 151. Additionally, the treatment of compound 151 with hydrazine hydrate gave
(3,5,6-trichloropyridin-2-yl)hydrazine-carboxylate (152). When the acid hydrazide 152 was then
subjected to aqueous potassium thiocyanate, 2-(2-((3,5,6-trichloropyridin-2-yl)oxy)acetyl)hydrazine-
carbothioamide (153) was obtained. Cyclization of 153 in basic media afforded 1H-1,2,4-
triazole-5(4H)-thione 154) [71]. On the other side, various S-alkylated products 155a–e were obtained
via reacting substituted benzyl chlorides with triazolethiones 154. However, the reaction of morpholine,
formaldehyde, and compound 155a–e gave the N-alkylated morpholino-triazolethiones 156a–e, which
Molecules 2020, 25, 3036 23 of 54
on oxidation with H2O2 in acidic media gave 3,4,5-trisubstituted-1,2,4- triazoles 157a–e in 54–69%
yields [71]. The synthesized compounds 157a–e screened for their antimicrobial activity revealed that
157c exhibited better antibacterial and antifungal activities than the other compounds (Scheme 41) [71].
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from good to excellent yields (55–95%) from thiosemicarbazide (20) and different cyclic ketones 
using different catalysts, the most effective catalyst was 1,1′-sulfinyldipyridinium bis(hydrogen 
sulfate) ionic liquid which gave high yield and short reaction time in alcohol at room temperature 
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The synthesis of 1-acetyl-5′-thioxospiro[indoline-3,3′-[1,2,4]triazolidin]-2-one (170), in 87% 
yield, was achieved by the reaction of 1-acetylindoline-2,3-dione with thiosemicarbazide 20 
catalyzed by acidic ionic liquid (Scheme 47). Compound 170 showed good antibacterial activity 
[76].  
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thiones 193a–e via formation of thiosemicarbazone intermediates 192a–e, which was obtained from 
the reaction of 3,3-dimethyl-phenylpiperidin-4-ones 191a–e with 20 (Scheme 53) [82]. 
 
Scheme 53. Synthesis of tetrazaspiro[4.5]decane-3-thiones 193a–e. 
Similarly, the reaction of 3-alkyl-2,6-diphenylpyran-4-ones 194a–f with 20 or 4-phenyl 
hydrazinecarbothioamides 23 gave thiosemicarbazones 195a–f. Oxidative cyclization of 195a–f with 
hydrogen peroxide led to the expected 7,9-diphenyl-8-oxa-1,2,4-triazaspiro[4.5]decane-3-thiones 
196a–f. The synthesized compounds were tested for antimicrobial activity against Staphylococcus 
aureus, Escherichia coli, Pseudomonas aeruginosa, Salmonella typhi, Aspergillus flavus, Aspergillus niger, 
Candida albicans, and Rhizopus sp. Compounds 196e and 196f showed potent antibacterial activity 
against E. coli and S. typhi. However, compounds 196d and 196f were potent against Rhizopus Sp., 
whereas compound 196e gave significant antifungal activity against Aspergillus flavus (Scheme 54) 
[83]. 
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The synthesis of mono and bipolar surfactants 201a–d and 202a–d was achieved by the reaction 
of 3-methyl-1H-1,2,4-triazole-5(4H)-thione (30c) and 3-phenyl-1H-1,2,4-triazole-5(4H)-thione (30d) 
with various alkyl bromides. However, in the case of n-dodecyl bromide, a mixture of two isomers 
203 and 204 was obtained from the reaction of 201a–d and 202a–d with another molecule of alkyl 
bromide. In addition, bis-1,2,4-triazoles 205a,b were obtained from the reaction of linear 
dibromoalkanes with 3-methyl-1H-1,2,4-triazole-5(4H)-thione (30c) (Scheme 56) [85].  
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3. Reactions of 1,2,4-Triazolethiones
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The synthesis of mono and bipolar surfactants 201a–d and 202a–d was achieved by the reaction of
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various alkyl bromides. However, in the case of n-dodecyl bromide, a mixture of two isomers 203 and
204 was obtained from the reaction of 201a–d and 202a–d with another molecule of alkyl bromide.
In addition, bis-1,2,4-triazoles 205a,b were obtained from the reaction of linear dibromoalkanes with
3-methyl-1H-1,2,4-triazole-5(4H)-thione (30c) (Scheme 56) [83].
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Reaction of various 1,2,4-triazolethiones 19a–g with alkyl or aryl isothiocyanates gave
1-substituted-3-(4-((4-substituted-5-thioxo-4,5-dihydro-1H-1,2,4-triazole-3-yl)-methoxy)phenyl)thio-
ureas 209a–g (Scheme 58). All the synthesized compounds 209a–g evaluated against antiviral,
anti-HIV, and anti-tuberculosis activity showed that compound 209g was the most active one with
79% inhibition against Mycobacterium tuberculosis H37Rv and also gave moderate protection against
Coxsackievirus B4 with an MIC value of 16 mg/mL and a selectivity index of 5 [21].
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Condensation of 4-amino-5-(pyridin-3-yl)-1,2,4-triazolidine-3-thione (11o) with 4-
chlorobenzaldehyde yielded 4-chlorobenzylideneamino-5-(pyridin-3-yl)-1,2,4-triazolidine-3-thione 
(210). (E)-4-Chloro-benzylideneamino-5-(methylthio)-3-(pyridin-3-yl)-1,2,4-triazole 211 was 
synthesized form the reaction of 210 with methyl iodide. Finally, the trisubstituted 1,2,4-triazole 215 
was synthesized in presence of iodide anion through the intermediates 212–214 (Scheme 59) [87].  
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yields. Besides, the reaction of compounds 216a–i with iodine afforded (E)-5-((2,3-diiodoallyl)thio)-
3-(substituted phenyl)-1,2,4-triazoles 217a–i in 75–92% yields and traces of thiazolotriazoles 218a–i 
in 44–59% yields (Scheme 60) [88]. 
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The reaction of propargyl bromide with 5-(substituted phenyl)-1,2,4-triazolidine-3-thiones
21a,c–j yielded 3-substituted-5-(prop-2-yn-1-ylthio)-4,5-dihydro-1H-1,2,4-triazoles 216a–i in 62–77%
yields. Besides, the reaction of compounds 216a–i with iodine afforded (E)-5-((2,3-diiodoallyl)thio)-
3-(substituted phenyl)-1,2,4-triazoles 217a–i in 75–92% yields and traces of thiazolotriazoles 218a–i in
44–59% yields (Scheme 60) [86].
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Reaction of 4-phenyl-5-(pyridin-3-yl)-1,2,4-triazole-3-thiol (92b) with ethyl bromoacetate gave
1,2,4-triazolthioacetate 225 which on reacting with hydrazine hydrate afforded the desired
acetohydrazide 226. Moreover, the synthesis of various N-substituted-2-(2-((4-phenyl-5-(pyridin-3-yl)-
4H-1,2,4-triazole-3-yl)thio)acetyl)hydrazinecarbothioamides 227a–f was achieved by reacting 226 with
isothiocyanates (Scheme 62) [88].
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yl)-4H-1,2,4-triazole-3-yl)thio)acet l)hydrazinecarb thioamides 227a–f was achieved by reacting 
226 with isothiocyanates (Scheme 62) [89].  
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119a,b with ethyl acrylate gave ethyl 3-(3-((diphenylphosphoryl)methyl)-4-substituted-5-thioxo-4,5-
dihydro-1H-1,2,4-triazol-1-yl)propanoates 228a–c [71] (Scheme 63). 
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synthesized upon reacting 4-aminotriazolethiones 229a–e with different aldehydes. Additionally, 
reaction of 230a–e with chloroacetic acid and catalyzation by pyridine gave 2-((4-(substituted 
benzylideneamino)phenoxymethyl-4H-1,2,4-triazole-3-yl)thio)acetic acid derivatives 231a–e in 66–
70% yields. The former compounds were screened for antimicrobial activities showing that 
compounds 231b and 231d have good antifungal activities against Aspergillus niger, Cryptococcus 
neoformans, and Aspergillus fumigatus at MIC of 0.25 μg/mL compared to the standard drug 
fluconazole with MIC of 1 μg/mL (Scheme 64) [90]. 
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Sche e 63. Synthesis of triazolethiones 228a–c.
The Schiff bases of 4-amino-3-((phenoxy)methyl)-1H-1,2,4-triazole-5(4H)-thiones 230a–e were
synthesized upon reacting 4-aminotriazolethiones 229a–e with different aldehydes. Additionally,
reaction of 230a–e with chloroacetic acid and catalyzation by pyridine gave 2-((4-(substituted
benzylideneamino)phenoxymethyl-4H-1,2,4-triazole-3-yl)thio)acetic acid derivatives 231a–e in 66–70%
yields. The former compounds were screened for antimicrobial activities showing that compounds
231b and 231d have good antifungal activities against Aspergillus niger, Cryptococcus neoformans,
and Aspergillus fumigatus at MIC of 0.25 µg/mL compared to the standard drug fluconazole with MIC
of 1 µg/mL (Scheme 64) [90].
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Refluxing of 3-(adamantan-1-yl)-4-methyl-triazolethione 131b with 2-aminochloride 
derivatives afforded S-(2-aminomethyl) and N-(2-aminomethyl) derivatives 238 and 132g in 3:1 
ratio, respectively [92]. Besides, 3-(adamantyl)-5-((2-methoxyethyl)thio)-4-phenyl-1,2,4-triazole 239 
was obtained from the reaction of 1-bromo-2-methoxyethanone with 3-(adamantan-1-yl)-4-phenyl-
1H-1,2,4-triazole-5(4H)-thione 131a. However, in the case of ethyl bromo acetate, two products were 
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3-(adamantan-1-yl)-5-((substituted benzyl)thio)-4-phenyl-4H-1,2,4-triazoles 242a–e (Scheme 66). The 
synthesized compounds were tested against anti-inflammatory and antimicrobial activities. 
Compounds 240 and 241 exhibited good anti-inflammatory activity, whereas compounds 240, 241, 
and 242c–e proved potent antibacterial activity against the tested microorganisms (Scheme 66) [92]. 
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Refluxing of 3-(adamantan-1-yl)-4-methyl-triazolethione 131b with 2-aminochloride derivatives
afforded S-(2-aminomethyl) and N-(2-aminomethyl) derivatives 238 and 132g in 3:1 ratio,
respectively [92]. Besides, 3-(adamantyl)-5-((2-methoxyethyl)thio)-4-phenyl-1,2,4-triazole 239 was
obtained from the reaction of 1-bromo-2-methoxyethanone with 3-(adamantan-1-yl)-4-phenyl-
1H-1,2,4-triazole-5(4H)-thione 131a. However, in the case of ethyl bromo acetate, two products
were formed, ethyl 2-((5-(adamantan-1-yl)-4-phenyl-1,2,4-triazole-3-yl)thio)acetate 240 that converted
to 2-((5-(adamantan-1-yl)-4-phenyl-4H-1,2,4-triazole-3-yl)thio)acetic acid 241. Moreover, reaction of
aryl methyl halides with 3-(adamantan-1-yl)-4-phenyl-1H-1,2,4-triazole-5(4H)-thione 131a afforded
3-(adamantan-1-yl)-5-((substituted benzyl)thio)-4-phenyl-4H-1,2,4-triazoles 242a–e (Scheme 66).
The synthesized compounds were tested against anti-inflammatory and antimicrobial activities.
Compounds 240 and 241 exhibited good anti-inflammatory activity, whereas compounds 240, 241, and
242c–e proved potent antibacterial activity against the tested microorganisms (Scheme 66) [92].
 
Scheme 66. Synthesis of thio-4-phenyl-4H-1,2,4-triazoles 242a–e. 
The reaction of aminotriazolethiones 243a–i with different aldehydes afforded various 
arylidenes 244a–l, which upon reacting with 133 gave substituted triazoles 245a–i (Scheme 67). The 
bioassay of antibacterial and antifungal activities of 245a–i revealed that they have better antifungal 
than antibacterial activities; also, compounds 245b,c,f,j,k,l showed excellent antifungal activity 
against Candida albicans with an MIC of 16 μg/mL [93].  
 
Scheme 67. Synthesis of substituted triazoles 245a–i. 
. , , .
reaction of aminotriazolethiones 243a–i with different aldehydes affor d various arylidene
244a–l, which upon reacting with 133 gave substitut d triazoles 245 –i (Scheme 67). The bioassay
of ntibacterial and antifungal activities of 245a–i revealed th t they have bett r an ifungal than
antibacteri l activities; also, compounds 245b,c,f,j,k,l showed excellent antifungal activity gainst
Candida albicans with an MIC of 16 µg/mL [93].
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piperazine or 4-substituted pyrimidyl/phenyl/pyridylpiperazine in ethanol at room temperature led to
new Mannich bases 247a–c and 248a–c in 67–74% and 72–83% yields, respectively [94] (Scheme 68).
The bioassay of the synthesized compounds revealed that these compounds could be used as new
fungicides, whereas compounds 247a–c exhibited higher and wider fungicidal activities comparable
with that of control triadimefon (Scheme 68) [94].
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Scheme 69. Reaction of triazolethione 249 with pipemidic acid 250. 
Schiff bases of triazolethiones 67a–c were obtained from the reaction of 4-substituted 
benzaldehyde with 4-amino-3-substituted-1,2,4-triazole-5-thiones 11a–c. Besides, the reaction of 
compounds 67a–c, formaldehyde, and 4-substituted piperazine gave the corresponding Mannich 
base 252a–c. In addition, bis-Mannich base derivatives 253a–c were synthesized in case of reaction 
of 67a–c with piperazine (Scheme 70) [52].  
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oxo-5,8-dihydropyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives 251, which exhibited significant
antimicrobial activities [95] (Scheme 69).
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Schiff bases of triazolethiones 67a–c were obtained from the reaction of 4-substituted benzaldehyde
with 4-amino-3-substituted-1,2,4-triazole-5-thiones 11a–c. Besides, the reaction of compounds 67a–c,
for aldehyde, and 4-substituted piperazine gave the corresponding Mannich base 252a–c. In addition,
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Scheme 70. Synthesis of triazolethiones 252- and 253a–c. 
Reaction of 3,4-disubstituted triazolethioles 66a–c with 2-bromoacetophenones gave ((3,4-
disubstituted-1,2,4-triazole-3-yl)thio)-1-phenyl-ethanones 254a–c in 70–82% yields and ((3,4-
disubstituted-1,2,4-triazole-3-yl)thio)-1-(4-fluorophenyl)ethanones 255a–c in 72–85% yields [96]. The 
screening of the antioxidant activity using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) method 
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while 1,2,4-triazole-3-thiones showed good antioxidant activity (Scheme 71) [96].
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Synthesis of Pyrazolo-1,2,4-triazoles 
Compounds 4-Amino-5-(3-substituted pyrazolyl)triazolethiols 259a–d, 260a,b, and 261a–c in 
61–78% yields were synthesized via reacting 4-aminotriazole-3-thiol (258), dimethoxy-N,N-
dimethylmethanamine, and carbonyl compounds using acidic media (orthophosphoric acid) as 
catalyst [98] (Scheme 73). The mechanism describing the role of orthophosphoric acid is presented 
in Scheme 74. 
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3.2. Synthesis of Substituted Triazolethiones
Synthesis of Pyrazolo-1,2,4-triazoles
Compounds 4-Amino-5-(3-substituted pyrazolyl)triazolethiols 259a–d, 260a,b, and 261a–c
in 61–78% yields were synthesized via reacting 4-aminotriazole-3-thiol (258), dimethoxy-N,N-
dimethylmethanamine, and carbonyl compounds using acidic media (orthophosphoric acid) as
catalyst [98] (Scheme 73). The mechanism describing the role of orthophosphoric acid is presented in
Scheme 74.
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Condensation of 5-chloro-1-phenyl-3-(substituted)-1H-pyrazole-4-carbaldehyde with amino-
triazolethiones 11d,e furnished the corresponding Schiff bases 246a,b. Bis-aminotriazolethiones 
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piperazine and formaldehyde in ethanol at room temperature) (Scheme 75) [61].  
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3.3. Synthesis of Fused Triazoles 
3.3.1. Synthesis of Fused Pyrazolotriazoles 
The synthesis of pyrazolotriazoles 265a–d was easily established in 75–80% yields from the 
reaction of 4-amino-5-(substituted indole)-1,2,4-triazole-3-thiols 263a–d with N-
arylhydrazonoacetates using basic media of triethylamine via the intermediate 264a–d. 
Desulfurization and ring contraction of compounds 264a–d gave the target compound 265a–d 
(Scheme 76) [99]. 
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Condensation of 5-chloro-1-phenyl-3-(substituted)-1H-pyrazole-4-carbaldehyde with
amino-triazolethiones 11d,e furnished the corresponding Schiff bases 246a,b. Bis-aminotriazolethiones
262a,b can be obtained effectively in high yields (83–89% yields upon reaction of 246a,b with piperazine
and formaldehyde in ethanol at room temperature) (Scheme 75) [61].
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The condensation reaction of 3-substituted-1,2,4-triazole 266a–c with chloroacetic acid in acidic 
media afforded thiazolotriazoles 267a–c in 65–69% yields. Interestingly, the synthesized compounds 
were screened for their antioxidant and antimicrobial activities [100] (Scheme 77). Compound 267a 
exhibited effective antimicrobial activity towards all the tested organisms. 
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However, in case of refluxing of 4H-1,2,4-triazole-3-thiol (268) with chloroacetic acid and 
different aldehydes or isatin derivatives in acidic media, various 5-substituted arylidene-
thiazolotriazoles 269a–e in 49–68% yields or (Z)-5-(1-acetyl-2-oxo-1H-indol-3(2H,3aH,7aH)-
ylidene)thiazolo[3,2-b]-1,2,4-triazol-6(5H)-ones 270 were efficiently synthesized in 40% yield 
(Scheme 78) [101]. Screening of the obtained compounds for anticancer activity revealed that 5-
arylidene-[1,3]thiazolo[3,2-b][1,2,4]triazol-6-ones 269a–e exhibited more potent anticancer activity 
than respective amides [101]. 
3.3.2. Synthesis of Thiazolotriazoles
The condensation reaction of 3-substituted-1,2,4-triazole 266a–c with chloroacetic acid in acidic
media afforded thiazolotriazoles 267a–c in 65–69% yields. Interestingly, the synthesized compounds
were screened for their antioxidant and antimicrobial activities [100] (Scheme 77). Compound 267a
exhibited effective antimicrobial activity towards all the tested organisms.
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Shah et al. [104]. have reported the synthesis of thiazolotriazoles 275 in 77–85% yields via 
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3.3.3. Synthesis of Triazolothiadiazoles 
Triazolo[3,4-b][1,3,4]thiadiazoles 276a–g and 277a–e were obtained from refluxing of different 
aromatic carboxylic acids with 11o in the presence of phosphorous oxychloride [105]. Screening of 
the synthesized compounds against lung carcinoma (H157) and kidney fibroblast cell lines (BHK-21) 
showed that compound 277d has the highest inhibition activity of 74.0% for BHK-21 cells which is 
the same as that of standard drug vincristine (74.5%). Compound 276c,d,g showed less inhibition 
values , and triazolothidiazole 276a was the most potent compound with inhibition value of 85.5%, 
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Scheme 82. Synthesis of triazolo[1,3,4]-thiadiazoles 276 and 277. 
The synthesis of fused heterocyclic[1,2,4]triazolo[3,4-b]-1,3,4-thiadiazoles 278a–c and 281a–c 
was done by the reaction of 4-amino-5-(4-((4-X-phenyl)sulfonyl)phenyl)-4H-1,2,4-triazole-3-thiol 
(11p,q) with aryl isothiocyanates or with various aromatic acids. Antimicrobial screening of the 
synthesized compounds showed that they had good antimicrobial activity (Scheme 83) [106]. 
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3.3.3. Synthesis of Triazolothiadiazoles
Triazolo[3,4-b][1,3,4]thiadiazoles 276a–g and 277a–e were obtained from refluxing of different
aromatic carboxylic acids with 11o in the presence of phosphorous oxychloride [105]. Screening of
the synthesized compounds against lung carcinoma (H157) and kidney fibroblast cell lines (BHK-21)
showed that compound 277d has the highest inhibition activity of 74.0% for BHK-21 cells which is the
same as that of standard drug vincristine (74.5%). Compound 276c,d,g showed less inhibition values,
and triazolothidiazole 276a was the most potent compound with inhibition value of 85.5%, whereas
compounds 276b,f and 277a exhibited less inhibition values (Scheme 82) [105].
Molecules 2020, 25, 3036 42 of 54
 
Scheme 81. Synthesis of thiazolotriazole 275. 
3.3.3. Synthesis of Triazolothiadiazoles 
Triazolo[3,4-b][1,3,4]thiadiazoles 276a–g and 277a–e were obtained from refluxing of different 
aromatic carboxylic acids with 11o in the presence of phosphorous oxychloride [105]. Screening of 
the synthesized compounds against lung carcinoma (H157) and kidney fibroblast cell lines (BHK-21) 
showed that compound 277d has the highest inhibition activity of 74.0% for BHK-21 cells which is 
the same as that of standard drug vincristine (74.5%). Compound 276c,d,g showed less inhibition 
values , and triazolothidiazole 276a was the most potent compound with inhibition value of 85.5%, 




















Reagents and conditions: A = Ar-CO2H; POCl3 -




276: Ar = a; 2F,4-Cl-C6H3; b, 3Cl,4-F-C6H3;c = 2-furanyl; d, 3-furanyl;
e , 2-CH3-3-furanyl; f, 2Cl,4,5-diF-C6H2; g = 4-OC2H5-C6H4CH2
277a-e
277: R = a, 2-OH; b, R = 4-OH; c, R = 2-CH3; d, R = 4-OCH3; e, R = 4-F
R
 
Scheme 82. Synthesis of triazolo[1,3,4]-thiadiazoles 276 and 277. 
The synthesis of fused heterocyclic[1,2,4]triazolo[3,4-b]-1,3,4-thiadiazoles 278a–c and 281a–c 
was done by the reaction of 4-amino-5-(4-((4-X-phenyl)sulfonyl)phenyl)-4H-1,2,4-triazole-3-thiol 
(11p,q) with aryl isothiocyanates or with various aromatic acids. Antimicrobial screening of the 
synthesized compounds showed that they had good antimicrobial activity (Scheme 83) [106]. 
.
The synthesis of fused heterocyclic[1,2,4]triazolo[3,4-b]-1,3,4-thiadiazoles 278a–c and 281a–c was
done by the reaction of 4-amino-5-(4-((4-X-phenyl)sulfonyl)phenyl)-4H-1,2,4-triazole-3-thiol (11p,q)
with aryl isothiocyanates or with various aromatic acids. Antimicrobial screening of the synthesized
compounds showed that they had good antimicrobial activity (Scheme 83) [106].
 
Scheme 83. Synthesis of triazolo[1,3,4]-thiadiazoles 278–281a–c. 
When 3-substituted methylaminotriazolethione 11r was condensed with different aldehydes, 
arylidene derivatives of triazolethiones 282a–c were obtained in 54–66% yield, whereas 
triazolothiadiazoles 283a–c, in 48–74% yields, were synthesized from the reaction of compound 
282a–c with iodine. In addition, 6-mercapto-1,2,4-triazolothiadiazoles 284 were synthesized upon 
reaction of 11r with CS2 in pyridine. The synthesis of 4-((6-(ethylthio)-[1,2,4]triazolo[3,4-b][1,3,4]-
thiadiazol-3-yl)methyl)-2H-chromen-2-one 285 was occurred from reaction of 11r with methyl 
iodide in basic media in 55–75% yields. Moreover, 6-methylthio derivative 285 reacted with 
different aromatic amines to give triazolothiadiazoles 286a–c (in 55–75% yields). The obtained 
compounds were evaluated in vitro as anticancer agents in the human colon cancer (HCT 116) cell 
line where the aminosulfanyl derivative 286c exhibited high anticancer activity (Scheme 84) [37].  
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Scheme 94. Synthesis of triazolothiadiazines 314.
Refluxing of 11e with N-aryl-2-oxopropanehydrazonoylchloride 315a–e afforded (Z)-6-methyl-
7-(2-aryllhydrazono)-3-(trifluoromethyl)-7H-[1,2,4]triazolo[3,4-b]-[1,3,4]thiadiazine (317) via the
formation of intermediate 316 [118]. Screening of the anticancer activities revealed that compounds
316a,e were the most active inhibitors against HEPG-2 cell line, whereas compound 316a was active
against HCT cell line [118] (Scheme 95).
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4. Conclusions 
In this review, we are trying to focus attention on the routes of triazole-thione synthesis. Since, 
triazolethione-thiols have gained considerable importance in medicinal chemistry, due to their 
broad spectrum as antiviral, antibacterial, anticancer, etc. agents, their synthesis has become of 
great interest. We also give spots on the biology of the target molecule as prospective antiviral 
drugs. 
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63. Pieczonka, A.M.; Mlostoń, G.; Heimgartner, H. Synthesis of Bis-Heterocyclic 1H-Imidazole 3-Oxides from
3-Oxido-1H-imidazole-4-carbohydrazides. Helv. Chim. Acta 2012, 95, 404–414. [CrossRef]
Molecules 2020, 25, 3036 52 of 54
64. Ezabadi, I.R.; Camoutsis, C.; Zoumpoulakis, P.; Geronikaki, A.; Soković, M.; Glamočilija, J.; Ćirić, A.
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